Published in J Surg Res on December 01, 1998
Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol (2002) 1.76
A2A receptors in inflammation and injury: lessons learned from transgenic animals. J Leukoc Biol (2007) 1.68
Caffeine decreases exhaled nitric oxide. Thorax (2002) 1.62
Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol (2009) 1.56
Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol (2002) 1.50
Up-regulation of A 2B adenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol (2008) 1.10
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc Res (2010) 1.07
Does nitric oxide allow endothelial cells to sense hypoxia and mediate hypoxic vasodilatation? In vivo and in vitro studies. J Physiol (2003) 1.00
Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res (2012) 0.96
Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming. Front Pharmacol (2014) 0.86
Role of adenosine signaling in penile erection and erectile disorders. J Sex Med (2010) 0.86
A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts. Am J Physiol Heart Circ Physiol (2013) 0.85
Adenosine receptors: expression, function and regulation. Int J Mol Sci (2014) 0.84
A(2A) adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE-knockout mice. J Exp Pharmacol (2011) 0.80
Pleiotropic effects of thyroid hormones: learning from hypothyroidism. J Thyroid Res (2011) 0.80
Exogenous adenosine enhances caspase-3 activity in warm renal ischaemia. Pflugers Arch (2003) 0.79
Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase. J Physiol (2000) 0.79
Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies. Biomed Res Int (2014) 0.79
Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors. Br J Pharmacol (2015) 0.77
Regulation of atherosclerosis and associated risk factors by adenosine and adenosine receptors. Curr Atheroscler Rep (2012) 0.77
Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. Anemia (2012) 0.76
Glucose-induced intestinal vasodilation via adenosine A1 receptors requires nitric oxide but not K(+)(ATP) channels. J Surg Res (2010) 0.75
Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice. J Mol Cell Cardiol (2015) 0.75
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Prevention of venous thromboembolism. Chest (2001) 5.59
Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14
Prevention of venous thromboembolism. Chest (1995) 2.69
Prevention of venous thromboembolism. Chest (1998) 2.24
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J (1982) 1.82
Prevention of venous thromboembolism. Chest (1992) 1.81
Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart. Am J Physiol (1999) 1.74
Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation (1998) 1.64
Physician practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg (1992) 1.63
Extended indications for placement of an inferior vena cava filter. J Vasc Surg (1989) 1.62
Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res (1971) 1.55
Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med (1994) 1.54
Sites of adenosine production in cardiac and skeletal muscle. Am J Physiol (1973) 1.49
Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. Circ Res (1971) 1.46
Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg (1999) 1.45
Development and validation of a Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol (1996) 1.45
A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med (1999) 1.41
Edge damage effect in in vitro frog skin preparations. Am J Physiol (1968) 1.33
Effect of beta-adrenoreceptor blockade on rat cardiac and skeletal muscle pH. Am J Physiol (1976) 1.29
Rabbit heart can be "preconditioned" via transfer of coronary effluent. Am J Physiol (1999) 1.28
Autologus saphenous vein femoropopliteal bypass: analysis of 298 cases. Surgery (1976) 1.28
Physician practices in the prevention of venous thromboembolism. Ann Intern Med (1991) 1.28
Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol (1993) 1.25
Brachial plexus injury following median sternotomy. J Thorac Cardiovasc Surg (1980) 1.23
Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med (1987) 1.20
Application of the "G-suit" to the control of hemorrhage in massive trauma. Ann Surg (1971) 1.18
Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res (1982) 1.15
Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res (1983) 1.14
A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med (2000) 1.12
Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma (1995) 1.11
Surgical management of arteriosclerotic femoral aneurysms. Surgery (1973) 1.08
Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol (2000) 1.06
Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3',5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle. Circ Res (1978) 1.06
Clinical management of the symptomatic but unruptured abdominal aortic aneurysm. J Vasc Surg (1990) 1.06
Endometrial carcinoma after stilbestrol therapy in gonadal dysgenesis. N Engl J Med (1972) 1.03
Axillary artery compression and thrombosis in throwing athletes. J Vasc Surg (1990) 1.02
The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med (1992) 1.02
Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol (2000) 1.02
Noninvasive detection of carotid stenosis following endarterectomy. Arch Surg (1981) 1.01
Ultrasound-guided compression of iatrogenic femoral pseudoaneurysm failure, recurrence, and long-term results. J Vasc Surg (1995) 1.01
Prediction of the development of sigmoid ischemia on the day of aortic operations. Indirect measurements of intramural pH in the colon. Arch Surg (1986) 1.01
Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res (1997) 1.00
Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol (1995) 1.00
Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol (1987) 0.98
Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol (1992) 0.98
Mechanisms of activation of cardiac glycogen phosphorylase in ischemia and anoxia. Circ Res (1973) 0.97
Persistent shedding of Salmonella enteritidis from the udder of a cow. Can Vet J (1991) 0.97
Occlusive impedance phlebography: a diagnostic procedure for venous thrombosis and pulmonary embolism. Prog Cardiovasc Dis (1975) 0.97
Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans? J Vasc Surg (1997) 0.95
Inhibition by adenosine of catecholamine-induced increase in rat atrial contractility. Am J Physiol (1980) 0.94
Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg (1987) 0.93
Long-term regulation of proximal tubule acid-base transporter abundance by angiotensin II. Kidney Int (2006) 0.92
An easy and rapid method for the measurement of [gamma-32P]ATP specific radioactivity in tissue extracts obtained from in vitro rat heart preparations labeled with 32Pi. Anal Biochem (1981) 0.92
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med (1990) 0.91
Classroom lectures do not influence family practice residents' learning. Acad Med (1998) 0.91
Recommendations for incorporating palliative care education into the acute care hospital setting. Acad Med (1999) 0.90
Measurement by fluorescence of interstitial adenosine levels in normoxic, hypoxic, and ischemic perfused rat hearts. Circ Res (1987) 0.90
A prospective study of the incidence of deep venous thrombosis in hospitalized children. J Vasc Surg (1996) 0.90
Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease. J Vasc Surg (2000) 0.89
Spontaneous tibial artery thrombosis associated with varicella pneumonia and free protein S deficiency. J Vasc Surg (1998) 0.89
Adenosine reduces the Ca2+ transients of isoproterenol-stimulated rat ventricular myocytes. Am J Physiol (1991) 0.89
Applicability and interpretation of electrocardiographic stress testing in patients with peripheral vascular disease. Am J Surg (1981) 0.89
Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol (1986) 0.89
Role of extracellular and intracellular adenosine in the attenuation of catecholamine evoked responses in guinea pig heart. J Mol Cell Cardiol (1984) 0.89
Optimal grafting methods for the small abdominal aorta. J Cardiovasc Surg (Torino) (1987) 0.89
Function and structure of perfused bullfrog kidney. Am J Physiol (1977) 0.88
Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol (1997) 0.88
Long-term survival and quality of life following ruptured abdominal aortic aneurysm. Arch Surg (1988) 0.87
Traumatic pseudoaneurysm following blunt trauma. J Trauma (1986) 0.87
Vasopressin-dependent short-term regulation of aquaporin 4 expressed in Xenopus oocytes. Neuroscience (2009) 0.87
Marbofloxacin for the treatment of experimentally induced Mycoplasma haemofelis infection in cats. J Vet Intern Med (2008) 0.87
Dissociations between changes in myocardial cyclic adenosine monophosphate and contractility. Circ Res (1975) 0.87
The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle. Circ Res (1976) 0.87
Venous thromboembolism. Risk factors and prophylaxis. Clin Chest Med (1995) 0.87
Adenosine A2a-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and -dependent mechanisms. Am J Physiol (1999) 0.86
Genomic organization of the mammalian SLC14a2 urea transporter genes. J Membr Biol (2007) 0.86
Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg (1995) 0.86
Impedance phlebography: technique, interpretation, and results. Arch Surg (1972) 0.86
Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. J Surg Res (1996) 0.86
Comorbidities and exercise capacity in older patients with intermittent claudication. Vasc Med (2001) 0.86
Long-term follow-up of Greenfield inferior vena cava filter placement in children. J Vasc Surg (2001) 0.86
Diagnosis of deep venous thrombosis by measurement of electrical impedance. Am J Surg (1970) 0.86
Diagnosis of deep vein thrombosis. Review of clinical evaluation and impedance plethysmography. Am J Surg (1985) 0.85
Diagnosis of occult deep vein thrombosis by a noninvasive bedside technique. Surgery (1971) 0.85
Adenosine and calcium alter adrenergic-induced intact heart protein phosphorylation. Am J Physiol (1984) 0.85